Wellington Management Group LLP bought a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 150,632 shares of the construction company's stock, valued at approximately $4,171,000. Wellington Management Group LLP owned about 0.18% of Aspen Aerogels at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Sora Investors LLC acquired a new stake in Aspen Aerogels during the third quarter worth about $3,461,000. State Street Corp boosted its position in Aspen Aerogels by 0.6% in the 3rd quarter. State Street Corp now owns 1,410,543 shares of the construction company's stock worth $39,058,000 after purchasing an additional 8,344 shares in the last quarter. Redwood Grove Capital LLC grew its stake in shares of Aspen Aerogels by 10.9% during the 3rd quarter. Redwood Grove Capital LLC now owns 147,705 shares of the construction company's stock worth $4,090,000 after purchasing an additional 14,495 shares during the period. Maven Securities LTD purchased a new position in shares of Aspen Aerogels during the 3rd quarter valued at approximately $415,000. Finally, Morse Asset Management Inc acquired a new position in shares of Aspen Aerogels in the 3rd quarter valued at $264,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.
Aspen Aerogels Price Performance
Shares of NYSE ASPN traded down $0.48 during mid-day trading on Wednesday, reaching $12.49. The company's stock had a trading volume of 1,821,187 shares, compared to its average volume of 1,624,779. The stock has a 50-day moving average of $16.74 and a two-hundred day moving average of $22.59. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The stock has a market capitalization of $1.02 billion, a P/E ratio of 1,250.25 and a beta of 2.11. Aspen Aerogels, Inc. has a 1-year low of $10.75 and a 1-year high of $33.15.
Wall Street Analysts Forecast Growth
ASPN has been the subject of a number of analyst reports. Barclays decreased their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a research report on Tuesday, November 12th. TD Cowen boosted their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the company a "buy" rating in a research report on Tuesday, August 20th. Piper Sandler reduced their target price on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a research note on Tuesday, October 22nd. HC Wainwright reissued a "buy" rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Finally, Roth Mkm reduced their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a research report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $28.70.
View Our Latest Stock Analysis on ASPN
Insider Activity at Aspen Aerogels
In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the company's stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. This represents a 11.58 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 4.30% of the stock is owned by corporate insiders.
Aspen Aerogels Company Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Recommended Stories
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.